Skip to main content
Beryl Drugs Ltd. logo

Beryl Drugs Ltd. — Investor Relations & Filings

Ticker · 524606 ISIN · INE415H01017 LEI · 984500CC594C0ZE90971 BSE.NS Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS 524606

About Beryl Drugs Ltd.

https://www.beryldrugs.com/

Beryl Drugs Ltd. focuses on the manufacturing and marketing of formulations, specializing in intravenous (IV) fluids and small volume parenterals. The company produces a diverse range of medical solutions, including electrolyte replacements such as Dextrose and Sodium Chloride, alongside therapeutic injectables like Ciprofloxacin and Metronidazole. Its operations center on providing critical care products for clinical and hospital environments. The product portfolio covers multiple therapeutic categories, emphasizing the production of sterile liquid medications designed for patient treatment and recovery.

Recent filings

Filing Released Lang Actions
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve consider and approve the Audited ....
Regulatory Filings Classification · 85% confidence The document is a formal notice to the stock exchange of an upcoming Board of Directors meeting to consider and approve the audited financial statements and related items. It is not itself the financial report, nor a change in board or management, nor a shareholder proxy solicitation. It is a routine regulatory announcement to the exchange, fitting the catch-all Regulatory Filings category.
2026-05-20 English
PROCEEDINGS OF EGM
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a filing under SEBI (LODR) Reg. 30 disclosing the detailed proceedings of an extraordinary general meeting, including agendas, voting modes, and vote outcomes. It is not an AGM presentation, annual report, or management discussion – rather it provides the official results of shareholder resolutions passed at a general meeting. This aligns with the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-05-13 English
VOTING RESULTS OF EGM HELD ON 11.05.2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal declaration of poll and e-voting results for an Extraordinary General Meeting (EGM), including the Scrutinizer’s consolidated report and detailed voting outcomes under SEBI LODR Regulation 44. It does not present financial statements or request votes; it simply publishes vote results, matching the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-05-12 English
SCRUTINIZERS REPORT FOR THE EGM HELD ON 11TH MAY 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 87% confidence The document is a formal submission to the stock exchange of the consolidated e-voting and poll results from an Extraordinary General Meeting (EGM), including the Scrutinizer’s Report, in compliance with SEBI LODR Regulation 44(3). It does not present financial statements or a report itself but discloses voting outcomes. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-12 English
RELATED PARTY TRANSACTION(S) WITH AMINOVA INFUSIONS PVT LTD
Regulatory Filings Classification · 95% confidence The document is a formal stock exchange filing under Regulation 30 and Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It discloses approval of a material related party transaction at an Extraordinary General Meeting and includes the certified copy of the resolution and explanatory statement. This is not a financial report itself (e.g., IR, 10-K) but a regulatory announcement to the exchange. It does not fit other specialized categories, so it belongs in the general Regulatory Filings category (RNS).
2026-05-11 English
REGULARISATION OF APPOINTMENT OF MRS. NEHA SARDA AS INDEPENDENT DIRECTOR OF THE COMPANY
Board/Management Information Classification · 95% confidence The document is a Reg. 30 intimation to the stock exchange under SEBI LODR announcing the shareholders’ approval at an EGM for the regularisation of the appointment of Mrs. Neha Sarda as an Independent Director, along with certified true copy of the board resolution. This clearly falls under announcements of changes in the company’s board of directors, matching the Board/Management Information category.
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.